CO67 Network Meta-Analysis to Compare the Efficacy Between Different Classes of PCSK9 Inhibitors, siRNA Vs. PCSK9 mAb, in Asian Patients With Hypercholesterolemia at Increased Cardiovascular Risk
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.155
https://www.valueinhealthjournal.com/article/S1098-3015(24)00270-5/fulltext
Title :
CO67 Network Meta-Analysis to Compare the Efficacy Between Different Classes of PCSK9 Inhibitors, siRNA Vs. PCSK9 mAb, in Asian Patients With Hypercholesterolemia at Increased Cardiovascular Risk
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00270-5&doi=10.1016/j.jval.2024.03.155
First page :
Section Title :
Open access? :
No
Section Order :
10971